Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) SHH

Currency In CNY

AD

Valuation

Market Cap4.1B
Enterprise Value4.78B
P/E Ratio76.17
PEG Ratio1.48
Price/Sales Ratio5.79
Price/Book Ratio3.56
Enterprise/Revenue6.22
Enterprise/EBITDA34.32

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.07
Operating Margin0.09
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.05

Income Statement

Revenue1.5B
Revenue/Share7.03
Gross Profit526.71M
EBITDA307.19M
Net Income102.23M
Diluted EPS0.47

Balance Sheet

Total Cash641.51M
Total Cash/Share2.88
Total Debt1.16B
Total Debt/Equity0.49
Current Ratio1.45
Book Value Per Share11.2

Price History

52-Week Change87.1
52-Week High70.39
52-Week Low18.8
Moving Average 50 Days50.16
Moving Average 200 Days29.92

Statistics

Average Volume45.1M
Shares Outstanding238.37M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.05
Trailing Annual Dividend Yield0.13
Payout Ratio0.21
Last Split Factor69851:50000
Last Split DateJune 08, 2022
AD